Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients

Molecular and Cellular Endocrinology

Volumn 135, Issue 1, 1997, Pages 41-47

  Federici, M ^a   Porzio, O ^a   Zucaro, L ^a   Giovannone, B ^a   Borboni, P ^a   Marini, M A ^a   Lauro, D ^a   Sesti, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; IODINE 125; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOASSAY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INSULINEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADIPOSE TISSUE; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOASSAY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROTEIN HYBRIDIZATION; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

EID: 0031434946     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00185-8     Document Type: Article

References (37)

1. Bolinder J., Lindblad A., Engfeldt P., Arner P. Studies of acute effects of insulin-like growth factors I and II in human fat cells. J. Clin. Endocrinol. Metab. 65:1987;732-737.
2. Bonora E., Moghetti P., Zancanaro C. Estimates of in vivo insulin action in man: comparision of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J. Clin. Endocrinol. Metab. 68:1989;374-378.
3. Boulware S.D., Tamborlane W.V., Mathews L.S., Sherwin R.S. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am. J. Physiol. 262:1992;E130-E133.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1978;248-254.
5. Di Girolamo M., Eden S., Enberg G., Isaksson O., Lonnroth P., Hall K., Smith U. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 205:1986;15-19.
6. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J.H., Masiarz F., Kan Y.W., Goldfine I.D., Roth R.A., Rutter W.J. The structural basis for hormone-activated transmembrane signalling. Cell. 40:1985;747-758.
7. Federici M., Zucaro L., Porzio O., Massoud R., Borboni P., Lauro D., Sesti G. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 98:1996;2887-2893.
8. Federici M., Porzio O., Zucaro L., Fusco A., Borboni P., Lauro D., Sesti G. Distribution of insulin/insulin like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol. 129:1997;121-126.
9. Forsayeth J.R., Montemurro A., Maddux B.A., De Pirro R., Goldfine I.D. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J. Biol. Chem. 262:1987;4134-4140.
10. Frattali A.L., Pessin J.E. Relationship between α subunit ligand occupancy and β subunit autophosphorylation in insulin/insulin-like growth factor-I hybrid receptors. J. Biol. Chem. 268:1993;7393-7400.
11. Freidenberg G.R., Henry R.R., Klein H.H., Reichart D.R., Olesky J.M. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J. Clin. Invest. 79:1987;240-250.
12. Guler H.P., Zapf J., Froesch E.R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. New Engl. J. Med. 317:1987;137-140.
13. Hussain M.A., Schmitz O., Mengel A., Keller A., Christiansen J.S., Zapf J., Froesch E.R. Insulin-like growth factor-I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 92:1993;2249-2256.
14. Kasuya J., Paz B., Maddux B.A., Goldfine I.D., Hefta S.A., Fujita-Yamaguchi Y. Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry. 32:1993;13531-13536.
15. Kern P.A., Marshall S., Eckel R.H. Regulation of lipoprotein lipase in primary cultures of human adipocytes. J. Clin. Invest. 75:1985;199-208.
16. Kolaczynski J.M., Caro J.F. Insulin-like growth factor-I therapy in diabetes: physiological basis, clinical benefits, and risks. Ann. Int. Med. 120:1994;47-55.
17. Laager R., Keller U. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type II (non-insulin-dependent) diabetic subjects. Diabetologia. 36:1993;966-971.
18. Langlois W.J., Sasaoka T., Yip C.C., Olefsky J.M. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type Insulin-like growth factor 1 or insulin receptor. Endocrinology. 136:1995;1978-1986.
19. Moses A.C., Young S.C.J., Morrow L.A., O'Brien M., Clemmons D.R. Recombinant human insulin-like-growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 45:1996;91-100.
20. Moxham C.P., Duronio V., Jacobs S. Insulin-like growth factor-I receptors β-subunit heterogeneity. J. Biol. Chem. 264:1989;13238-13244.
21. National Diabetes Data Group, 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057.
22. Rosenzweig S.A., Zetterstrom C., Benjamin A. Identification of retinal insulin receptor using site-specific antibodies to a carboxyl-terminal peptide of the human insulin receptor α-subunit. J. Biol. Chem. 265:1990;18030-18034.
23. Seely B.L., Reichart D.R., Takata Y., Yip C.C., Olefsky J.M. A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology. 136:1995;1635-1641.
24. Sesti G., Marini M.A., Tullio A.N., Montemurro A., Borboni P., Fusco A., Accili D., Lauro R. Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. Biochem. Biophys. Res. Commun. 181:1991;1419-1424.
25. Sesti G., D'Alfonso R., Vargas Punti M.D., Frittitta L., Trischitta V., Liu Y.Y., Borboni P., Longhi R., Montemurro A., Lauro R. Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor. Diabetologia. 38:1995;445-453.
26. Sinha M.K., Pories W.J., Flickinger E.G., Meelheim D., Caro J.F. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes. 36:1987;620-625.
27. Sinha M.K., Buchanan C., Leggett N., Martin L., Khazanie P.G., Dimarchi R., Pories W.J., Caro J.F. Mechanism of IGF-I-stimulated glucose transport in human adipocytes: demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes. 38:1989;1217-1225.
28. Soos M.A., Siddle K. Immunological relationships between receptors for insulin and insulin-like growth factor-I. Biochem. J. 263:1989;553-563.
29. Soos M.A., Whittaker J., Lammers R., Ullrich A., Siddle K. Receptor for insulin and insulin-like growth factor-I can form hybrid dimers. Biochem. J. 270:1990;383-390.
30. Soos M.A., Fielld C.E., Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290:1993;419-426.
31. Treadway J.L., Morrison B.D., Goldfine I.D., Pessin J.E. Assembly of insulin/insulin-like growth factor-I hybrid receptors in vitro. J. Biol. Chem. 264:1989;21450-21453.
32. Turkalji I., Keller U., Ninnis R., Vosmeer S., Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor I on glucose, lipid, and leucine metabolism in man. J. Clin. Endocrinol. Metab. 75:1992;1186-1191.
33. Ullrich A., Bell R.J., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.C., Tsubokawa M., Moson A., Seeburg P.H., Grunfeld C., Rosen O.M., Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 313:1985;756-761.
34. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., Jacobs S., Francke U., Ramachandran J., Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparision with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:1986;2503-2512.
35. Usala A.L., Madigan T., Burguera B., Sinha M.K., Caro J.F., Cunningham P., Powell J.G., Butler P.C. Treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes. New Engl. J. Med. 327:1992;853-857.
36. Valensise H., Liu Y.Y., Federici M., Lauro D., Dell'anna D., Romanini C., Sesti G. Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin resistant women with gestational hypertension. Diabetologia. 39:1996;952-960.
37. Zenobi P.D., Jaeggi-Groisman S.E., Riesen W.F., Roder M.E., Froesch E.R. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes. J. Clin. Invest. 90:1992;2234-2241.